These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3017375)

  • 1. Focal brain stimulation attenuates morphine withdrawal behaviors.
    Beaulieu CL; Thorn BE
    Behav Neurosci; 1986 Aug; 100(4):504-11. PubMed ID: 3017375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla.
    Bederson JB; Fields HL; Barbaro NM
    Somatosens Mot Res; 1990; 7(2):185-203. PubMed ID: 2378192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auricular microelectrostimulation: naloxone-reversible attenuation of opiate abstinence syndrome.
    Malin DH; Murray JB; Crucian GP; Schweitzer FC; Cook RE; Skolnick MH
    Biol Psychiatry; 1988 Dec; 24(8):886-90. PubMed ID: 2852967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcutaneous electrical stimulation with Limoge current potentiates morphine analgesia and attenuates opiate abstinence syndrome.
    Auriacombe M; Tignol J; Le Moal M; Stinus L
    Biol Psychiatry; 1990 Oct; 28(8):650-6. PubMed ID: 2173629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of morphine withdrawal signs in the rat after chronic treatment with naloxone.
    Suzuki T; Fukagawa Y; Misawa M
    Eur J Pharmacol; 1990 Mar; 178(2):239-42. PubMed ID: 2158457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavior of monkeys during opiate withdrawal and locus coeruleus stimulation.
    Grant SJ; Huang YH; Redmond DE
    Pharmacol Biochem Behav; 1988 May; 30(1):13-9. PubMed ID: 3174735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associative factors in tolerance to analgesia produced by electrical stimulation in the brainstem.
    Paul D; Phillips AG
    Behav Neurosci; 1990 Feb; 104(1):207-16. PubMed ID: 2156521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms.
    Haffmans J; Dzoljic MR
    Gen Pharmacol; 1987; 18(1):103-5. PubMed ID: 3549428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opiate withdrawal behavior after focal brain stimulation.
    Williams DA; Thorn BE
    Pharmacol Biochem Behav; 1984 Nov; 21(5):699-703. PubMed ID: 6542676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
    Cox B; Ary M; Lomax P
    J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enkephalinergic neurons in the periaqueductal gray and morphine withdrawal.
    Fukunaga Y; Kishioka S
    Jpn J Pharmacol; 2000 Mar; 82(3):175-80. PubMed ID: 10887947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An intraventricular infusion model for inducing morphine dependence in rats: quantitative assessment of precipitated withdrawal.
    Huffman RD; Simmons KE; Lum JT
    Behav Neurosci; 1985 Oct; 99(5):861-80. PubMed ID: 3843305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dorsal noradrenergic bundle lesions fail to alter opiate withdrawal or suppression of opiate withdrawal by clonidine.
    Britton KT; Svensson T; Schwartz J; Bloom FE; Koob GF
    Life Sci; 1984 Jan; 34(2):133-9. PubMed ID: 6537983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.
    Frenois F; Cador M; Caillé S; Stinus L; Le Moine C
    Eur J Neurosci; 2002 Oct; 16(7):1377-89. PubMed ID: 12405997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is morphine dependence mediated exclusively by the Mu receptor?
    Adams RE; Wooten GF
    Neurochem Res; 1993 Oct; 18(10):1041-5. PubMed ID: 8255352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats.
    Fukagawa Y; Katz JL; Suzuki T
    Eur J Pharmacol; 1989 Oct; 170(1-2):47-51. PubMed ID: 2558895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-cranial electrical stimulation attenuates the severity of naloxone-precipitated morphine withdrawal in rats.
    Dougherty PM; Dafny N
    Life Sci; 1989; 44(26):2051-6. PubMed ID: 2747416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ability of periaqueductal gray subdivisions and adjacent loci to elicit analgesia and ability of naloxone to reverse analgesia.
    Thorn BE; Applegate L; Johnson SW
    Behav Neurosci; 1989 Dec; 103(6):1335-9. PubMed ID: 2558678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.